176 related articles for article (PubMed ID: 27960078)
1. Dormancy Stems the Tide of Chemotherapy.
Pal D; Heidenreich O; Vormoor J
Cancer Cell; 2016 Dec; 30(6):825-826. PubMed ID: 27960078
[TBL] [Abstract][Full Text] [Related]
2. Targeting the bone marrow microenvironment in acute leukemia.
Karantanou C; Godavarthy PS; Krause DS
Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
[TBL] [Abstract][Full Text] [Related]
3. Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
Uy GL; Hsu YM; Schmidt AP; Stock W; Fletcher TR; Trinkaus KM; Westervelt P; DiPersio JF; Link DC
Leuk Res; 2015 Dec; 39(12):1437-42. PubMed ID: 26467815
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.
Ebinger S; Özdemir EZ; Ziegenhain C; Tiedt S; Castro Alves C; Grunert M; Dworzak M; Lutz C; Turati VA; Enver T; Horny HP; Sotlar K; Parekh S; Spiekermann K; Hiddemann W; Schepers A; Polzer B; Kirsch S; Hoffmann M; Knapp B; Hasenauer J; Pfeifer H; Panzer-Grümayer R; Enard W; Gires O; Jeremias I
Cancer Cell; 2016 Dec; 30(6):849-862. PubMed ID: 27916615
[TBL] [Abstract][Full Text] [Related]
5. Leukemia propagating cells rebuild an evolving niche in response to therapy.
Duan CW; Shi J; Chen J; Wang B; Yu YH; Qin X; Zhou XC; Cai YJ; Li ZQ; Zhang F; Yin MZ; Tao Y; Mi JQ; Li LH; Enver T; Chen GQ; Hong DL
Cancer Cell; 2014 Jun; 25(6):778-93. PubMed ID: 24937459
[TBL] [Abstract][Full Text] [Related]
6. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.
Boyerinas B; Zafrir M; Yesilkanal AE; Price TT; Hyjek EM; Sipkins DA
Blood; 2013 Jun; 121(24):4821-31. PubMed ID: 23589674
[TBL] [Abstract][Full Text] [Related]
7. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.
Gerby B; Veiga DF; Krosl J; Nourreddine S; Ouellette J; Haman A; Lavoie G; Fares I; Tremblay M; Litalien V; Ottoni E; Kosic M; Geoffrion D; Ryan J; Maddox PS; Chagraoui J; Marinier A; Hébert J; Sauvageau G; Kwok BH; Roux PP; Hoang T
J Clin Invest; 2016 Dec; 126(12):4569-4584. PubMed ID: 27797342
[TBL] [Abstract][Full Text] [Related]
9. The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.
Gaynes JS; Jonart LM; Zamora EA; Naumann JA; Gossai NP; Gordon PM
Haematologica; 2017 Apr; 102(4):e136-e139. PubMed ID: 28034988
[No Abstract] [Full Text] [Related]
10. A screening-based approach to circumvent tumor microenvironment-driven intrinsic resistance to BCR-ABL+ inhibitors in Ph+ acute lymphoblastic leukemia.
Singh H; Shelat AA; Singh A; Boulos N; Williams RT; Guy RK
J Biomol Screen; 2014 Jan; 19(1):158-67. PubMed ID: 23989453
[TBL] [Abstract][Full Text] [Related]
11. Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL.
Balandrán JC; Dávila-Velderrain J; Sandoval-Cabrera A; Zamora-Herrera G; Terán-Cerqueda V; García-Stivalet LA; Limón-Flores JA; Armenta-Castro E; Rodríguez-Martínez A; Leon-Chavez BA; Vallejo-Ruiz V; Hassane DC; Pérez-Tapia SM; Ortiz-Navarrete V; Guzman ML; Pelayo R
Front Immunol; 2021; 12():746492. PubMed ID: 34737747
[TBL] [Abstract][Full Text] [Related]
12. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A
Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294
[TBL] [Abstract][Full Text] [Related]
13. Targeting chemokines for acute lymphoblastic leukemia therapy.
Hong Z; Wei Z; Xie T; Fu L; Sun J; Zhou F; Jamal M; Zhang Q; Shao L
J Hematol Oncol; 2021 Mar; 14(1):48. PubMed ID: 33743810
[TBL] [Abstract][Full Text] [Related]
14. A rare subgroup of leukemia stem cells harbors relapse-inducing potential in acute lymphoblastic leukemia.
Senft D; Jeremias I
Exp Hematol; 2019 Jan; 69():1-10. PubMed ID: 30261200
[TBL] [Abstract][Full Text] [Related]
15. Targeting leukemic stem cells by breaking their dormancy.
Essers MA; Trumpp A
Mol Oncol; 2010 Oct; 4(5):443-50. PubMed ID: 20599449
[TBL] [Abstract][Full Text] [Related]
16. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
17. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Hongo T; Yajima S; Sakurai M; Horikoshi Y; Hanada R
Blood; 1997 Apr; 89(8):2959-65. PubMed ID: 9108416
[TBL] [Abstract][Full Text] [Related]
18. Linking the hematopoietic microenvironment to imatinib-resistant Ph+ B-ALL.
Dorshkind K; Witte ON
Genes Dev; 2007 Sep; 21(18):2249-52. PubMed ID: 17875661
[No Abstract] [Full Text] [Related]
19. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
[TBL] [Abstract][Full Text] [Related]
20. Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia.
Irving JA
Br J Haematol; 2016 Mar; 172(5):655-66. PubMed ID: 26568036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]